Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-20-000216
Filing Date
2020-01-14
Accepted
2020-01-14 06:30:12
Documents
2
Period of Report
2020-01-13

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k_011420.htm 6-K 5386
2 PRESS RELEASE exh_991.htm EX-99.1 12220
  Complete submission text file 0001171843-20-000216.txt   18729
Mailing Address 117 AVENUE DE LUMINY BP 30191 MARSEILLE I0 13009
Business Address 117 AVENUE DE LUMINY BP 30191 MARSEILLE I0 13009 33430303030
Innate Pharma SA (Filer) CIK: 0001598599 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39084 | Film No.: 20524932
SIC: 2836 Biological Products, (No Diagnostic Substances)